Table III.

Hospital-acquired E. coli susceptibility data by year

	2017-18	2018-19	2019-20	2020-21	2021-22	Total
Total number of episodes	134	153	194	157	159	797
Co-amoxiclav resistant	53 (39.6%)	75 (39.9%)	44 (22.7%)	74 (47.1%)	68 (42.8%)	314 (39.4%)
Ciprofloxacin resistant	43 (32.1%)	55 (35.9%)	53 (27.3%)	55 (35.0%)	39 (24.5%)	245 (30.7%)
Gentamicin resistant	15 (11.2%)	27 (17.6%)	37 (19.1%)	21 (13.4%)	24 (15.1%)	124 (15.6%)
Amikacin resistant	4 (3.0%)	0	3 (1.5%)	3 (1.9%)	2 (1.3%)	12 (1.5%)
ESBL producing enterobacterales	30 (22.4%)	35 (22.9%)	42 (21.6%)	35 (22.3%)	33 (20.8%)	175 (22.0%)
Carbapenem resistant organisms	2 (1.5%)	1 (0.7%)	1 (0.5%)	1 (0.6%)	0	5 (0.6%)